Smart Pills in Pharmacy: Monitoring Adherence and Drug Response Through Ingestible Tech
Keywords:
Smart Pills, Medication Adherence, Ingestible Sensors, Digital Health Technology, Personalized MedicineAbstract
Smart pills, or ingestible sensors, represent a transformative innovation in pharmaceutical care by enabling real-time monitoring of patient adherence and physiological responses to medications. This review explores the development, mechanisms, applications, and challenges of smart pill technology, with a focus on its role in enhancing medication adherence, optimizing therapeutic outcomes, and integrating with digital health ecosystems. The paper also discusses regulatory, ethical, and economic considerations, while highlighting future directions for clinical implementation.
References
1. Kardas P. From non-adherence to adherence: can innovative solutions resolve a longstanding problem? Eur J Intern Med. 2024;119:6–12.
2. Al Meslamani AZ. Policy solutions for medication non-adherence: what can governments do? Expert Rev Pharmacoecon Outcomes Res. 2024;24:777–81.
3. Choo PW, Rand CS, Inui TS, Lee M-LT, Cain E, Cordeiro-Breault M, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–57.
4. Root L. High-Tech Adherence: Incorporating Smart Pill Technology Into Wellness Programs. Quinnipiac Heal LJ. 2016;19:121.
5. Avery M, Liu D. Bringing smart pills to market: FDA regulation of ingestible drug/device combination products. Food Drug LJ. 2011;66:329.
6. Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, et al. Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 2024;16:332.
7. Cummins G. Smart pills for gastrointestinal diagnostics and therapy. Adv Drug Deliv Rev. 2021;177:113931.
8. Minaam DSA, Abd-ELfattah M. Smart drugs: Improving healthcare using smart pill box for medicine reminder and monitoring system. Futur Comput Informatics J. 2018;3:443–56.
9. Faisal S, Samoth D, Aslam Y, Patel H, Park S, Baby B, et al. Key features of smart medication adherence products: updated scoping review. JMIR aging. 2023;6:e50990.
10. Cosgrove L, Morrill Z, Karter JM. Digital aripiprazole as a human technology. Econ Soc. 2021;50:359–73.
11. Aldeer M, Javanmard M, Martin RP. A review of medication adherence monitoring technologies. Appl Syst Innov. 2018;1:14.
12. Al Shammari YH, Al Shammari HA, Barak TM Bin, Alharbi BS, Alshammari ST, Alnais SA, et al. Smart Pills: the Future of Adherence Monitoring. Int J Health Sci (Qassim). 3:1–15.
13. Goffredo R, Accoto D, Guglielmelli E. Swallowable smart pills for local drug delivery: present status and future perspectives. Expert Rev Med Devices. 2015;12:585–99.
14. Klugman CM, Dunn LB, Schwartz J, Cohen IG. The ethics of smart pills and self-acting devices: autonomy, truth-telling, and trust at the dawn of digital medicine. Am J Bioeth. 2018;18:38–47.
15. Raikar AS, Kumar P, Raikar G (Vedant) S, Somnache SN. Advances and challenges in IoT-based smart drug delivery systems: a comprehensive review. Appl Syst Innov. 2023;6:62.
